Right, that's why they use pumps for spray paint. The venturi solely determines droplet size only among pump sprays.
You're basing your claims on your expert medical credentials, right?
I think we should leave these decisions to doctors, not you or EPA bureaucrats, don't you?
Yep.. EPA shouldn't be making decisions on inhaler/nebulizer designs. PERIOD..
And they aren't. International law, of which we are a signatory, is.
flacidman said:I led a team designing a nebulizer for CF medication. With a nebulizer, the droplet size is EXCEEDINGLY small and uniform. And this is used in high end (mostly clinical, not home use) drug delivery. Cost of these delivery systems is HIGH because of govt mandated reimbursements -- not cost of manufacture. Our nebulizer had no cost controls because it was designed to admin CF drugs at HOME rather than as out-patient. And therefore the govt reimbursement would be the SAME AMOUNT even if the patient didn't have to sit in a clinic for administration. THUS -- the govt took the efficiency improvement right OUT of the cost equation. Which is why -- costs for common techniques never go down no matter what technical innovations or cost savings are applied...
I paid $70 for my nebulizer, and pay $12.00/month for the medication. Next.
Must be easier to nebulize your drug and deliver it. In the case of the CF drug, the drug release had to be coordinated with a particular portion and velocity of the breath pattern to be effective.. Included the ability to measure the breath cycle and velocity. And the drug was WAY more expensive.
COULD HAVE cared about expense.. But no one did -- because they got paid the same for the procedure..